| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Finance and Controller | VP, Finance & Controller
1 company
Karen C Lam last filed a Form 4 in January 2021, as VP, Finance and Controller at RAPT. Karen C Lam's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 12,735 shares of RAPT. The RAPT filings lean toward selling, a net 4,728 shares.
Karen C Lam has 6 Form 4 filings on record from January 2020 to January 2021, all as VP, Finance and Controller at RAPT Therapeutics (RAPT), 2020–2021.
The 7 reported transactions were 3 open-market sales, 2 option or other derivative awards, 1 option exercise and 1 stock award.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $116K.
The largest open-market sale was 2,022 shares of RAPT at an average $28.14 on November 2, 2020, about $57K.
Shares as reported in the last Form 4 for each company; the most recent is from January 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2020 | RAPT Rapt Therapeutics, Inc. | VP, Finance and Controller | Sell | 2,022 | $28.14 | $56,899.08 | -13.7% | |
| Jun 25, 2020 | RAPT Rapt Therapeutics, Inc. | VP, Finance & Controller | Sell | 875 | $35.00 | $30,625.00 | -6.4% | |
| May 7, 2020 | RAPT Rapt Therapeutics, Inc. | VP, Finance & Controller | Sell | 1,831 | $15.40 | $28,197.40 | -14.5% |